Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A

Two syntheses are described for 1-[(2,4-di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indol-9-yl)-acetyl]pyrrolidine hydrochloride (PNU-142731A), a clinical candidate in the asthma area. The route involving the initial regioselective addition of glycine ethyl ester to commercially available 2,4,6-trichloropyr...

Full description

Saved in:
Bibliographic Details
Published in:Organic process research & development 2001-03, Vol.5 (2), p.144-151
Main Authors: Bundy, Gordon L, Banitt, Lee S, Dobrowolski, Paul J, Palmer, John R, Schwartz, Theresa M, Zimmermann, David C, Lipton, Michael F, Mauragis, Michael A, Veley, Michael F, Appell, Robert B, Clouse, Robert C, Daugs, Edward D
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43
cites cdi_FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43
container_end_page 151
container_issue 2
container_start_page 144
container_title Organic process research & development
container_volume 5
creator Bundy, Gordon L
Banitt, Lee S
Dobrowolski, Paul J
Palmer, John R
Schwartz, Theresa M
Zimmermann, David C
Lipton, Michael F
Mauragis, Michael A
Veley, Michael F
Appell, Robert B
Clouse, Robert C
Daugs, Edward D
description Two syntheses are described for 1-[(2,4-di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indol-9-yl)-acetyl]pyrrolidine hydrochloride (PNU-142731A), a clinical candidate in the asthma area. The route involving the initial regioselective addition of glycine ethyl ester to commercially available 2,4,6-trichloropyrimidine is particularly well-suited for large-scale operation, as it is short, proceeds in good yield, is operationally straightforward, and requires no chromatographic purification of intermediates.
doi_str_mv 10.1021/op000221p
format article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_op000221p</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a441107431</sourcerecordid><originalsourceid>FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43</originalsourceid><addsrcrecordid>eNpt0E1LAzEQBuAgCtbqwX-wFw9Co5lkk909lvWjhaKCFgSRJc2HTdkm62Z72H_vloonTzMDD8PMi9AlkBsgFG5DQwihFJojNAJOCea5eD8eepIzLECQU3QW42ZAXAAdoe_X3ndrE11Mgk3oJMV3DgNu-rYNtdPO9zUuZvvZbZ0OH-mE49Wn8zrUJk6SuVf1blBfydR3TsZuvZVJWTvvlKyTUnrttOxM8vK0xJDSjMH0HJ1YWUdz8VvHaPlw_1bO8OL5cV5OF1hSnnWDNrbgK1Aso5JazgQoK03OKWO2ULkkWQppYTIrBWXEGCBixYXSmQKtdcrG6PqwV7UhxtbYqhl-kG1fAan2WVV_WQ326mClitUm7Fo_XPaP-wF9YmbW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Bundy, Gordon L ; Banitt, Lee S ; Dobrowolski, Paul J ; Palmer, John R ; Schwartz, Theresa M ; Zimmermann, David C ; Lipton, Michael F ; Mauragis, Michael A ; Veley, Michael F ; Appell, Robert B ; Clouse, Robert C ; Daugs, Edward D</creator><creatorcontrib>Bundy, Gordon L ; Banitt, Lee S ; Dobrowolski, Paul J ; Palmer, John R ; Schwartz, Theresa M ; Zimmermann, David C ; Lipton, Michael F ; Mauragis, Michael A ; Veley, Michael F ; Appell, Robert B ; Clouse, Robert C ; Daugs, Edward D</creatorcontrib><description>Two syntheses are described for 1-[(2,4-di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indol-9-yl)-acetyl]pyrrolidine hydrochloride (PNU-142731A), a clinical candidate in the asthma area. The route involving the initial regioselective addition of glycine ethyl ester to commercially available 2,4,6-trichloropyrimidine is particularly well-suited for large-scale operation, as it is short, proceeds in good yield, is operationally straightforward, and requires no chromatographic purification of intermediates.</description><identifier>ISSN: 1083-6160</identifier><identifier>EISSN: 1520-586X</identifier><identifier>DOI: 10.1021/op000221p</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Organic process research &amp; development, 2001-03, Vol.5 (2), p.144-151</ispartof><rights>Copyright © 2001 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43</citedby><cites>FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bundy, Gordon L</creatorcontrib><creatorcontrib>Banitt, Lee S</creatorcontrib><creatorcontrib>Dobrowolski, Paul J</creatorcontrib><creatorcontrib>Palmer, John R</creatorcontrib><creatorcontrib>Schwartz, Theresa M</creatorcontrib><creatorcontrib>Zimmermann, David C</creatorcontrib><creatorcontrib>Lipton, Michael F</creatorcontrib><creatorcontrib>Mauragis, Michael A</creatorcontrib><creatorcontrib>Veley, Michael F</creatorcontrib><creatorcontrib>Appell, Robert B</creatorcontrib><creatorcontrib>Clouse, Robert C</creatorcontrib><creatorcontrib>Daugs, Edward D</creatorcontrib><title>Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A</title><title>Organic process research &amp; development</title><addtitle>Org. Process Res. Dev</addtitle><description>Two syntheses are described for 1-[(2,4-di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indol-9-yl)-acetyl]pyrrolidine hydrochloride (PNU-142731A), a clinical candidate in the asthma area. The route involving the initial regioselective addition of glycine ethyl ester to commercially available 2,4,6-trichloropyrimidine is particularly well-suited for large-scale operation, as it is short, proceeds in good yield, is operationally straightforward, and requires no chromatographic purification of intermediates.</description><issn>1083-6160</issn><issn>1520-586X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpt0E1LAzEQBuAgCtbqwX-wFw9Co5lkk909lvWjhaKCFgSRJc2HTdkm62Z72H_vloonTzMDD8PMi9AlkBsgFG5DQwihFJojNAJOCea5eD8eepIzLECQU3QW42ZAXAAdoe_X3ndrE11Mgk3oJMV3DgNu-rYNtdPO9zUuZvvZbZ0OH-mE49Wn8zrUJk6SuVf1blBfydR3TsZuvZVJWTvvlKyTUnrttOxM8vK0xJDSjMH0HJ1YWUdz8VvHaPlw_1bO8OL5cV5OF1hSnnWDNrbgK1Aso5JazgQoK03OKWO2ULkkWQppYTIrBWXEGCBixYXSmQKtdcrG6PqwV7UhxtbYqhl-kG1fAan2WVV_WQ326mClitUm7Fo_XPaP-wF9YmbW</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>Bundy, Gordon L</creator><creator>Banitt, Lee S</creator><creator>Dobrowolski, Paul J</creator><creator>Palmer, John R</creator><creator>Schwartz, Theresa M</creator><creator>Zimmermann, David C</creator><creator>Lipton, Michael F</creator><creator>Mauragis, Michael A</creator><creator>Veley, Michael F</creator><creator>Appell, Robert B</creator><creator>Clouse, Robert C</creator><creator>Daugs, Edward D</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010301</creationdate><title>Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A</title><author>Bundy, Gordon L ; Banitt, Lee S ; Dobrowolski, Paul J ; Palmer, John R ; Schwartz, Theresa M ; Zimmermann, David C ; Lipton, Michael F ; Mauragis, Michael A ; Veley, Michael F ; Appell, Robert B ; Clouse, Robert C ; Daugs, Edward D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bundy, Gordon L</creatorcontrib><creatorcontrib>Banitt, Lee S</creatorcontrib><creatorcontrib>Dobrowolski, Paul J</creatorcontrib><creatorcontrib>Palmer, John R</creatorcontrib><creatorcontrib>Schwartz, Theresa M</creatorcontrib><creatorcontrib>Zimmermann, David C</creatorcontrib><creatorcontrib>Lipton, Michael F</creatorcontrib><creatorcontrib>Mauragis, Michael A</creatorcontrib><creatorcontrib>Veley, Michael F</creatorcontrib><creatorcontrib>Appell, Robert B</creatorcontrib><creatorcontrib>Clouse, Robert C</creatorcontrib><creatorcontrib>Daugs, Edward D</creatorcontrib><collection>CrossRef</collection><jtitle>Organic process research &amp; development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bundy, Gordon L</au><au>Banitt, Lee S</au><au>Dobrowolski, Paul J</au><au>Palmer, John R</au><au>Schwartz, Theresa M</au><au>Zimmermann, David C</au><au>Lipton, Michael F</au><au>Mauragis, Michael A</au><au>Veley, Michael F</au><au>Appell, Robert B</au><au>Clouse, Robert C</au><au>Daugs, Edward D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A</atitle><jtitle>Organic process research &amp; development</jtitle><addtitle>Org. Process Res. Dev</addtitle><date>2001-03-01</date><risdate>2001</risdate><volume>5</volume><issue>2</issue><spage>144</spage><epage>151</epage><pages>144-151</pages><issn>1083-6160</issn><eissn>1520-586X</eissn><abstract>Two syntheses are described for 1-[(2,4-di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indol-9-yl)-acetyl]pyrrolidine hydrochloride (PNU-142731A), a clinical candidate in the asthma area. The route involving the initial regioselective addition of glycine ethyl ester to commercially available 2,4,6-trichloropyrimidine is particularly well-suited for large-scale operation, as it is short, proceeds in good yield, is operationally straightforward, and requires no chromatographic purification of intermediates.</abstract><pub>American Chemical Society</pub><doi>10.1021/op000221p</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1083-6160
ispartof Organic process research & development, 2001-03, Vol.5 (2), p.144-151
issn 1083-6160
1520-586X
language eng
recordid cdi_crossref_primary_10_1021_op000221p
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
title Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%202,4-Di-1-pyrrolidinyl-9H-pyrimido%5B4,5-b%5Dindoles,%20Including%20Antiasthma%20Clinical%20Candidate%20PNU-142731A&rft.jtitle=Organic%20process%20research%20&%20development&rft.au=Bundy,%20Gordon%20L&rft.date=2001-03-01&rft.volume=5&rft.issue=2&rft.spage=144&rft.epage=151&rft.pages=144-151&rft.issn=1083-6160&rft.eissn=1520-586X&rft_id=info:doi/10.1021/op000221p&rft_dat=%3Cacs_cross%3Ea441107431%3C/acs_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a257t-14ef95b1c372a2f5361cfae85233f9c8a074149e7fa6230ee106b56cd7c1ddd43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true